fluoride/neoplasms

FIELD OF THE DISCLOSURE The present disclosure relates to novel use and method for the treatment or prevention for treating or preventing cancer or for reducing or stopping the proliferation of cancer cells. BACKGROUND OF THE DISCLOSURE A broad group of diseases involving unregulated cell growth is

FIELD OF THE INVENTION The present invention relates to a method for diagnosing colon cancer and a diagnostic kit there for, more specifically, to a method for diagnosing colon cancer by detecting a colon cancer specific antigen, defensin .alpha.6 from the blood of patient and a diagnostic kit for

The present invention relates to fatty acid analogues which can be used for the treatment and/or prevention of cancer. More specifically, the invention relates to the use of the fatty acid analogues for the treatment and/or inhibition of primary and secondary neoplasms. BACKGROUND OF THE

TECHNICAL FIELD The present invention relates to a method for preventing or treating disease in a mammal, particularly a human, by maintaining a fluoride free diet. Many diseases can result from fluoride poisoning, including autism, cancer, Alzheimer's disease, multiple sclerosis, calcification of

TECHNICAL FIELD The invention generally relates to novel chemical compounds generated by structural modifications to an existing drug, osimertinib, via fluorination and/or deuteration, and pharmaceutical compositions and methods of preparation and use thereof. These compounds are biologically potent

DESCRIPTION 1. Field of the Invention The present invention is in the field of elemene analogs and elemenal analogues. In particular, the present invention relates to processes for the preparation of (-)-beta-elemene, (-)-beta-elemenal (a (-)-beta-elemene metabolite in mammals), (-)-beta-elemenol,

FIELD OF THE INVENTION This invention relates generally to compositions and methods useful in the prevention and treatment of osteoporosis and for bone and fracture repair. More specifically, the invention relates to slow-releasing calcium phosphate-based materials incorporating Mg, Zn, F, carbonate

This application is a request for U.S. examination under 35 U.S.C. .sctn.371 of International application No. PCT/US93/07875, filed Aug. 19, 1993. The present invention relates to new titanocene compounds. More particularly the invention relates to new titanocene complexes and methods for their

FIELD OF INVENTION The present invention is directed towards a new method of synthesis of .sup.18F-labeled pteroate or folate radiopharmaceuticals, wherein fluorine-18 is attached to a pteroate (or folate) or derivative thereof, through direct radiolabeling with .sup.18[F]fluoride, as well as

TECHNICAL FIELD The present invention relates to a monoclonal antibody useful for screening DPD-deficient cancer patients for whom administration of a pyrimidine fluoride-based antitumor agent is contraindicated; a hybridoma producing the monoclonal antibody; a method of immunochemically assaying